DengTang Liu
Shanghai Mental Health Center · liudengtang@smhc.org.cn · Chief Psychiatrist and Professor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name DengTang Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:33 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07918222 · Sequential Treatment Approaches for Treatment-Resistant SchizophreniaShanghai Mental Health Center · recruiting · Treatment-resistant Schizophrenia · principal investigator
- N/ANCT05694000 · Hippocampus DBS in Treatment-resistant SchizophreniaShanghai Mental Health Center · unknown · Treatment-resistant Schizophrenia · principal investigator
- N/ANCT05667961 · Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug DiscontinuationShanghai Mental Health Center · completed · Schizophrenia · principal investigator
- Ph3NCT04528095 · SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant SchizophreniaShanghai Mental Health Center · unknown · Treatment-resistant Schizophrenia · study chair
- N/ANCT01940939 · Study of Repetitive Transcranial Magnetic Stimulation in the Treatment of Cognitive Impairment in SchizophreniaShanghai Mental Health Center · completed · Schizophrenia · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:33 UTC. The ranking covers the 200 most relevant of 981 PubMed records, and a shared surname and initials can bring in a namesake. All 981 on PubMed
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.Cancer Discov · 20201,183 citationsRCR 55.1
- 570 citationsRCR 33.6
- [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].Zhejiang Da Xue Xue Bao Yi Xue Ban · 2020446 citationsRCR 24.1
- Calorie Restriction with or without Time-Restricted Eating in Weight Loss.N Engl J Med · 2022412 citationsRCR 33.5
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma.J Clin Oncol · 2019351 citationsRCR 12.8
- Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.JAMA Ophthalmol · 2018328 citationsRCR 17.7
- Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.N Engl J Med · 2018309 citationsRCR 10.4
- Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin.Diabetes Care · 2015257 citationsRCR 9.5
- Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.N Engl J Med · 2021247 citationsRCR 17.3
- Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes.Diabetes Care · 2015159 citationsRCR 5.9